GSK's Q3 Attributable Profit Falls; Turnover Grows

03:41 AM EDT, 10/28/2026 (MT Newswires) -- GSK (GSK.L) logged 1.54 billion pounds sterling in profit attributable to shareholders for the third quarter, compared with 2.01 billion pounds a year ago. EPS moved to 0.379 pound from 0.491 pound year over year, a Wednesday filing showed. For the three months ended Sept. 30, turnover was 8.89 billion pounds versus 8.55 billion pounds previously, the UK-listed drugmaker added. Analysts polled by FactSet were expecting 8.86 billion pounds in sales, 2.03 billion pounds in net income, and 0.5 pound in EPS. Meanwhile, the board declared a third interim dividend of 0.17 pound per share, payable on Jan. 7, 2027, to shareholders on record Nov. 13, 2026. It paid 0.16 pound per share in the year-ago period. The company reconfirmed its earlier growth guidance, including turnover at the upper half of the 3% to 5% range, core operating profit at the upper half of the 7% to 9% range, and core EPS at the lower half of the 7% to 9% range, at constant exchange rates, for 2026. GSK expects to pay a dividend of 0.70 pound per share for 2026.